查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1929696

全球医药物流仓储市场（按温度控制、服务类型、储存类型、所有权类型和最终用途划分）预测（2026-2032年）

Warehousing in Pharmaceutical Logistics Market by Temperature Control, Service Type, Storage Type, Ownership Type, End Use - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，医药物流仓储市场规模将达到 90.2 亿美元，到 2026 年将成长至 96.9 亿美元，到 2032 年将达到 142.1 亿美元，复合年增长率为 6.70%。

主要市场统计数据
基准年 2025 90.2亿美元
预计年份：2026年 96.9亿美元
预测年份：2032年 142.1亿美元
复合年增长率 (%) 6.70%

建构药品仓储的策略架构：低温运输完整性、法规遵循性和网路韧性如何融合，从而形成竞争优势

医药物流领域越来越依赖仓储营运的完整性来维持产品品质、满足监管要求并支持敏捷的供应链。治疗方法复杂性的增加、低温运输需求的扩大以及监管审查的加强，都已使仓储从单纯的成本中心跃升为一项战略能力。本执行摘要指出，仓储不仅是一个储存场所，更是一个影响病人用药、品牌信任和商业性弹性的关键枢纽。

技术应用、不断演变的外包模式以及永续性要求如何重塑药品仓储营运和策略重点？

技术、法规和商业模式的变革正在重新定义药品仓储营运的要求。先进的数位化工具，例如持续环境监测、边缘分析和整合仓库管理系统，已从检查应用转变为营运的必要组成部分。因此，许多营运商正从人工、间歇性的监控转向持续的、数据驱动的管理，从而降低风险并实现流程标准化。这种技术转变也提高了可追溯性和审核，而这正是监管机构和商业伙伴日益增长的需求。

探讨近期美国关税调整对营运的影响，以及这些调整对仓库规模、库存策略和供应链连续性的影响。

美国2025年前的关税趋势将增加药品供应链决策的复杂性，影响采购、运输管道和仓储策略。虽然成品药​​和许多活性药物成分受益于优惠待遇和统一的监管通讯协定，但辅助设备、包装材料和某些特殊组件则面临关税波动风险。这种波动迫使企业重新评估其在国内和国际分销点的库存结构。

多维度的细分框架从温度控制、服务、储存、最终用途和所有权等方面识别仓库功能，并将其与产品和商业风险相匹配。

这种细分方法为将仓储能力与产品风险状况和商业性需求相匹配提供了切实可行的观点。根据温度控制方式，市场可分为常温储存和温控储存。温控储存可进一步细分为冷藏保管储存和冷冻储存。这种基于温度的框架阐明了常温配送和专业低温运输营运在资本和合规方面的差异，并突显了不同细分市场在设施基础设施、能源管理和验证通讯协定方面存在显着差异的原因。

成熟市场和新兴市场的区域仓储趋势和分销重点正在影响设施设计合规策略和分销网络。

区域趋势正对全球主要市场的仓储需求和策略重点产生重大影响。在美洲，需求中心和监管预期正推动对地理位置分散的温控节点和强大的低温运输走廊的投资，以支持快速补货和高透明度。该地区对病患就医便利性和商业性上市速度的重视，使得靠近病患的配送管道和可靠的第三方伙伴关係尤为重要。

重新定义医药仓储物流领域的竞争优势：供应商能力、整合服务组合和数位化透明度的作用

仓储服务供应商之间的竞争优势日益凸显，其差异化体现在能力深度、合规性和与各类供应链服务的整合能力等方面。主要企业强调检验的低温运输基础设施、完善的品管系统以及端到端的文件记录能力，以支援监管机构的检查和审核。此外，这些能力通常还会透过投资数位化平台来增强，从而实现即时温度监控、自动偏差预警以及与客户核心系统的无缝资料整合。

物流和供应链高管可以采取哪些切实可行的步骤来增强低温运输完整性、合约柔软性以及可持续、有韧性的仓储营运？

行业领导者应优先考虑能够同时降低营运风险并加快新治疗方法上市速度的投资。首先，透过实施整合警报和自动化纠正工作流程的持续环境监测来加强数位化控制，从而减少人为因素对偏差的反应延迟。这有助于提高合规性，并减轻测试和不利事件调查期间的营运负担。其次，将外包策略与临床和商业生命週期相匹配，利用专用设施生产高价值或敏感产品，并采用灵活的合约或公共选项来管理低风险库存。这种组合能够在保持服务水准的同时提高资本效率。

为了检验我们对仓库管理的见解，我们采用了一种透明的混合方法研究途径，结合了专家访谈、设施观察、细分映射和情境分析。

本研究采用多种方法，确保整体性和检验。主要定性资料透过对製造商、经销商和仓储服务商的高级供应链、品质和监管负责人进行结构化访谈收集。验证和监控实践则透过对温控设施的现场考察进行观察。这些直接观察结果与二手资料进行了交叉比对，包括监管指南、行业白皮书以及关于低温运输物流和温控产品管理的最新学术文献。

最终综合分析强调，仓储是生命科学领域一项策略能力，它将产品完整性、监管准备和商业性回应能力连结起来。

对于检验公司而言，稳健的仓储策略是决定供应链韧性和商业性弹性的关键因素。温度控制要求、服务模式、储存配置和所有权选择相互作用，构成了一个复杂的决策空间，需要明确的优先事项和严谨的营运。投资于经过验证的低温运输基础设施、数位监控系统以及与实力雄厚的供应商伙伴关係的企业，更有可能降低产品风险，并提高其应对监管审查的能力。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章 美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依温度控制分類的医药物流仓储市场

  • 室温保存
  • 温控存储
    • 冷藏保管
    • 冷冻储存

9. 依服务类型分類的医药物流仓储市场

  • 合约仓库存储
    • 第三方物流
      • 3PL
      • 4PL
    • 附加价值服务
  • 专用仓库
  • 公共仓库

第十章：按储存类型分類的医药物流仓储市场

  • 散装存储
  • 托盘式存储
  • 货架存储

第十一章 依所有权类型分類的医药物流仓储市场

  • 出租房产
    • 长期租赁协议
    • 短期租赁协议
  • 自有财产
    • 直接所有权
    • 合资企业所有权

12. 依最终用途分類的医药物流仓储市场

  • 动物用药品
  • 人类药物
    • 非处方药
    • 处方药

第十三章：各地区医药物流仓储市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：依组别分類的医药物流仓储市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国医药物流仓储市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国医药物流仓储市场

第十七章：中国医药流仓储市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • ADAllen Pharma
  • Agility Public Warehousing Company KSCP
  • Alloga Ltd.
  • AmerisourceBergen Corporation
  • Bio Pharma Logistics
  • Cardinal Health, Inc.
  • CEVA Logistics AG
  • DB Schenker GmbH
  • DHL International GmbH
  • DSV A/S
  • FedEx Corporation
  • Geodis SA
  • Kuehne+Nagel International AG
  • McKesson Corporation
  • Rhenus SE & Co. KG
  • United Parcel Service, Inc.
  • XPO Logistics, Inc.
  • Yusen Logistics Co., Ltd
Product Code: MRR-0A380695189D

The Warehousing in Pharmaceutical Logistics Market was valued at USD 9.02 billion in 2025 and is projected to grow to USD 9.69 billion in 2026, with a CAGR of 6.70%, reaching USD 14.21 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 9.02 billion
Estimated Year [2026] USD 9.69 billion
Forecast Year [2032] USD 14.21 billion
CAGR (%) 6.70%

Setting the strategic context for pharmaceutical warehousing where cold chain integrity, regulatory compliance, and network resilience converge into competitive advantage

The pharmaceutical logistics landscape increasingly hinges on the integrity of warehousing operations that preserve product quality, meet regulatory expectations, and support responsive supply chains. Rising complexity in therapy modalities, extended cold chain requirements, and intensified scrutiny from regulators have elevated warehousing from a cost center to a strategic capability. This executive summary frames warehousing not simply as storage but as a pivotal node that influences patient access, brand trust, and commercial agility.

As companies diversify manufacturing footprints and seek resilient distribution pathways, warehousing decisions must account for a range of operational, regulatory, and commercial constraints. The interplay between temperature control, specialized handling for sensitive biologics, and the need for scalable capacity creates both challenges and opportunities. In many cases, warehouse design and service mix determine the feasibility of rapid product launches, recall management, and responsiveness during demand surges. Consequently, leaders must adopt a systems view that links physical assets, service partners, and governance mechanisms to measurable business outcomes.

This section establishes the context for subsequent analysis by outlining key pressures reshaping warehousing strategy, highlighting why logistics leaders should prioritize investments that balance compliance, cost efficiency, and agility. The following content delves into transformative shifts, tariff impacts, segmentation insights, regional dynamics, competitive positioning, and pragmatic recommendations to convert insight into action.

How technology adoption, evolving outsourcing models, and sustainability requirements are reshaping pharmaceutical warehousing operations and strategic priorities

Shifts across technology, regulation, and commercial models are redefining the expectations placed on pharmaceutical warehousing. Advanced digital tools such as continuous environmental monitoring, edge analytics, and integrated warehouse management systems have moved from pilot projects to operational essentials. As a result, many operators are transitioning from manual, episodic oversight to continuous, data-driven control that reduces risk and drives process standardization. This technological transition also enables enhanced traceability and auditability, which regulators and commercial partners increasingly demand.

Concurrently, the sector is witnessing structural changes in service delivery. The line between traditional public warehousing and comprehensive logistics partnerships is blurring as contract models expand to include value-added services, serialization, and regulatory support. Outsourcing decisions are shifting toward providers that can offer multi-modal capabilities and a proven track record in handling complex therapy profiles. Meanwhile, environmental goals and energy efficiency are introducing new design criteria for facilities, especially for temperature-controlled storage where energy intensity is high.

Taken together, these trends are reorganizing how stakeholders evaluate warehousing investments. Organizations that embed digital controls, prioritize interoperability with transport and clinical systems, and select partners with strong compliance frameworks will be better positioned to manage uncertainty while enabling faster commercialization and market responsiveness.

Navigating the operational consequences of recent U.S. tariff adjustments and their influence on warehousing footprint, inventory strategies, and supply continuity

Tariff dynamics in the United States through 2025 have added a layer of complexity to pharmaceutical supply chain decision-making, influencing sourcing, routing, and warehousing strategies. While finished pharmaceuticals and many active pharmaceutical ingredients benefit from preferential treatments and harmonized regulatory protocols, ancillary equipment, packaging materials, and certain specialty components have faced variable tariff exposure. This variability has prompted companies to re-evaluate the composition of inventory held domestically versus at international distribution hubs.

In response, several manufacturers and distributors have adopted dual-location strategies to mitigate cost volatility, placing non-critical stock in regional bonded or nearshore facilities while maintaining rigorous temperature-controlled capacity for sensitive products closer to demand centers. These adjustments seek to balance landed cost implications with service-level commitments and regulatory constraints. Additionally, tariff-driven shifts have accelerated conversations about nearshoring and vertical integration for critical inputs, which in turn affect warehousing footprint and throughput patterns.

Operationally, warehousing teams have had to enhance procurement coordination, increase invoice and duty visibility, and collaborate more closely with customs brokers to optimize flows. As trade policies continue to evolve, warehousing flexibility, inventory segmentation, and contractual agility with third-party providers remain essential levers to preserve continuity of supply and control total landed costs without compromising product integrity.

A multi-dimensional segmentation framework clarifying temperature, service, storage, end-use, and ownership lenses to align warehousing capabilities with product and commercial risk

Segmentation provides a practical lens to align warehousing capabilities with product risk profiles and commercial needs. Based on Temperature Control, market is studied across Ambient Storage and Temperature Controlled Storage. The Temperature Controlled Storage is further studied across Chilled Storage and Frozen Storage. This temperature-based framing clarifies the capital and compliance differentials between ambient distribution and specialized cold chain operations, and it underscores why facility infrastructure, energy management, and validation protocols vary significantly by segment.

Based on Service Type, market is studied across Contract Warehousing, Dedicated Warehousing, and Public Warehousing. The Contract Warehousing is further studied across Third Party Logistics and Value Added Services. The Third Party Logistics is further studied across 3PL and 4PL. This service-oriented segmentation highlights distinct contractual relationships and performance expectations, where dedicated models emphasize control and customization, contract arrangements offer integrated service bundles, and public warehousing supports flexibility for variable demand. The further distinctions among 3PL and 4PL roles illuminate differences in orchestration responsibilities and strategic oversight.

Based on Storage Type, market is studied across Bulk Storage, Palletized Storage, and Rack Storage. Storage configuration affects throughput, picking accuracy, and the economics of space utilization, with implications for automation opportunities and handling processes. Based on End Use, market is studied across Animal Pharmaceuticals and Human Pharmaceuticals. The Human Pharmaceuticals is further studied across Over The Counter and Prescription Drugs. End-use segmentation determines regulatory touchpoints, labeling complexity, and required traceability. Finally, based on Ownership Type, market is studied across Leased Property and Owned Property. The Leased Property is further studied across Long Term Lease and Short Term Lease. The Owned Property is further studied across Direct Owned and Joint Venture Owned. Ownership considerations shape capital allocation, responsiveness to demand fluctuations, and long-term strategic flexibility. Altogether, these segmentation lenses guide decisions about facility design, partner selection, and investment prioritization.

Regional warehousing dynamics and distribution priorities across established and emerging markets shaping facility design, compliance strategy, and distribution networks

Regional dynamics materially influence warehousing requirements and strategic priorities across major global markets. In the Americas, demand centers and regulatory expectations drive investments in geographically distributed temperature-controlled nodes and robust cold chain corridors that support fast replenishment and strong visibility. The region's emphasis on patient access and commercial launch speed places a premium on near-patient distribution options and high-reliability third-party partnerships.

In Europe, Middle East & Africa, heterogenous regulatory environments and diverse climatic conditions necessitate adaptable facility designs and region-specific compliance strategies. Cross-border movements within Europe demand harmonized labeling and serialization practices, while markets in the Middle East & Africa often require tailored logistics solutions that account for infrastructure variability and differing import regimes. These dynamics favor partners with regional expertise and the ability to provide compliant value-added services across multiple jurisdictions.

In the Asia-Pacific region, rapid biopharma manufacturing growth and expanding domestic demand are driving substantial capacity additions and an increased focus on cold chain modernization. The region's complex trade lanes and the prevalence of both large urban centers and remote distribution points underscore the need for modular warehousing solutions that balance centralized hubs with last-mile capabilities. Collectively, regional insights indicate that a one-size-fits-all warehousing strategy is insufficient; instead, firms should pursue geographically tailored approaches that respect local regulatory regimes, infrastructure realities, and commercial timelines.

How provider capabilities, integrated service portfolios, and digital transparency are redefining competitive differentiation in pharmaceutical warehousing and logistics

Competitive positioning among warehousing providers is increasingly differentiated by capability depth, regulatory track record, and integration with broader supply chain services. Leading firms emphasize validated cold chain infrastructure, strong quality management systems, and the ability to deliver end-to-end documentation that supports regulatory inspections and audits. These capabilities are often augmented by investment in digital platforms that enable real-time temperature monitoring, automated deviation alerts, and seamless data handoffs with customers' enterprise systems.

Service portfolios that bundle storage with serialization, relabeling, clinical trial support, and reverse logistics are gaining traction because they reduce handoffs and compress lead times. Providers that demonstrate transparent performance metrics, scalable capacity, and a history of managing high-value biologics command stronger commercial trust. At the same time, new entrants leveraging modular warehouses and cloud-native warehouse management systems are challenging incumbent models by offering rapid deployment and lower fixed-cost structures for emerging product lines.

Partnership criteria have therefore expanded beyond price and location; companies increasingly assess prospective providers on validation velocity, sustainability commitments, disaster recovery planning, and data interoperability. As a result, long-term relationships are now rooted in measurable KPIs, collaborative governance, and the ability to co-develop processes that mitigate product and patient risk.

Actionable steps for logistics and supply chain executives to strengthen cold chain integrity, contractual agility, and sustainable resilient warehousing operations

Industry leaders should prioritize investments that simultaneously reduce operational risk and enable faster time-to-market for new therapies. First, strengthen digital controls by deploying continuous environmental monitoring integrated with alerting and automated corrective workflows to reduce human latency in deviation response. This will improve compliance and lower the operational burden during inspections and adverse-event investigations. Second, align outsourcing strategies to the clinical and commercial lifecycle by using dedicated facilities for high-value or sensitive products and flexible contract or public options for lower-risk inventories. This mix permits capital efficiency while preserving service levels.

Third, build tariff and trade agility into procurement and inventory policies by maintaining segmented inventory pools that can be routed through bonded or nearshore facilities when supply chain cost pressures shift. Fourth, prioritize partnerships with providers offering validated cold chain credentials and value-added services such as serialization, kitting, and returns handling to reduce complexity across life-cycle transitions. Fifth, embed sustainability and energy-efficiency targets into facility selection and retrofit decisions, particularly for temperature-controlled operations where energy use is significant. Finally, establish clear governance with measurable KPIs for partner performance, and run periodic tabletop exercises to stress-test continuity plans and regulatory readiness. Together, these actions provide a pragmatic road map to fortify warehousing as a strategic enabler rather than a reactive constraint.

Transparent mixed-method research approach combining expert interviews, facility observations, segmentation mapping, and scenario analysis to validate warehousing insights

This research adopted a multi-method approach to ensure comprehensiveness and verifiability. Primary qualitative inputs were gathered through structured interviews with senior supply chain, quality, and regulatory leaders across manufacturers, distributors, and warehousing providers, supplemented by site visits to temperature-controlled facilities to observe validation and monitoring practices. These firsthand observations were triangulated with secondary sources including regulatory guidance, industry white papers, and recent academic literature on cold chain logistics and temperature-sensitive product management.

Analytical methods included capability mapping, gap analysis, and scenario planning to explore the implications of tariff shifts and regional distribution strategies. The segmentation framework was constructed by synthesizing operational criteria, service models, storage configurations, end-use distinctions, and ownership structures to create actionable decision lenses for executives. Quality assurance measures included cross-validation of emerging themes across multiple expert interviews and the review of compliance documentation to verify assertions regarding standard operating practices and technological adoption. Where possible, evidence-based examples and case observations were used to illustrate practical outcomes and lessons learned.

Final synthesis emphasizing warehousing as a strategic capability linking product integrity, regulatory readiness, and commercial responsiveness in life sciences

Robust warehousing strategy is an essential determinant of supply chain resilience and commercial agility for pharmaceutical companies. The interplay between temperature control requirements, service models, storage configurations, and ownership choices creates a complex decision space that must be navigated with clear priorities and operational rigor. Organizations that invest in validated cold chain infrastructure, digital monitoring, and partnerships with capable providers will reduce product risk and improve readiness for regulatory scrutiny.

Moreover, the evolving trade environment underscores the importance of flexible inventory strategies and geographically informed network design. By aligning warehousing models to therapy risk profiles and commercial lifecycles, companies can optimize capital deployment while preserving speed to market. Ultimately, warehousing should be treated as a strategic lever: when designed and governed effectively, it supports patient-centric outcomes, protects brand integrity, and enables organizations to respond nimbly to both market opportunity and disruption.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Warehousing in Pharmaceutical Logistics Market, by Temperature Control

  • 8.1. Ambient Storage
  • 8.2. Temperature Controlled Storage
    • 8.2.1. Chilled Storage
    • 8.2.2. Frozen Storage

9. Warehousing in Pharmaceutical Logistics Market, by Service Type

  • 9.1. Contract Warehousing
    • 9.1.1. Third Party Logistics
      • 9.1.1.1. 3PL
      • 9.1.1.2. 4PL
    • 9.1.2. Value Added Services
  • 9.2. Dedicated Warehousing
  • 9.3. Public Warehousing

10. Warehousing in Pharmaceutical Logistics Market, by Storage Type

  • 10.1. Bulk Storage
  • 10.2. Palletized Storage
  • 10.3. Rack Storage

11. Warehousing in Pharmaceutical Logistics Market, by Ownership Type

  • 11.1. Leased Property
    • 11.1.1. Long Term Lease
    • 11.1.2. Short Term Lease
  • 11.2. Owned Property
    • 11.2.1. Direct Owned
    • 11.2.2. Joint Venture Owned

12. Warehousing in Pharmaceutical Logistics Market, by End Use

  • 12.1. Animal Pharmaceuticals
  • 12.2. Human Pharmaceuticals
    • 12.2.1. Over The Counter
    • 12.2.2. Prescription Drugs

13. Warehousing in Pharmaceutical Logistics Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Warehousing in Pharmaceutical Logistics Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Warehousing in Pharmaceutical Logistics Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Warehousing in Pharmaceutical Logistics Market

17. China Warehousing in Pharmaceutical Logistics Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. ADAllen Pharma
  • 18.6. Agility Public Warehousing Company KSCP
  • 18.7. Alloga Ltd.
  • 18.8. AmerisourceBergen Corporation
  • 18.9. Bio Pharma Logistics
  • 18.10. Cardinal Health, Inc.
  • 18.11. CEVA Logistics AG
  • 18.12. DB Schenker GmbH
  • 18.13. DHL International GmbH
  • 18.14. DSV A/S
  • 18.15. FedEx Corporation
  • 18.16. Geodis SA
  • 18.17. Kuehne + Nagel International AG
  • 18.18. McKesson Corporation
  • 18.19. Rhenus SE & Co. KG
  • 18.20. United Parcel Service, Inc.
  • 18.21. XPO Logistics, Inc.
  • 18.22. Yusen Logistics Co., Ltd

LIST OF FIGURES

  • FIGURE 1. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNERSHIP TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AMBIENT STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AMBIENT STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AMBIENT STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CHILLED STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CHILLED STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CHILLED STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY FROZEN STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY FROZEN STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY FROZEN STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY 3PL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY 3PL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY 3PL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY 4PL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY 4PL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY 4PL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DEDICATED WAREHOUSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DEDICATED WAREHOUSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DEDICATED WAREHOUSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PUBLIC WAREHOUSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PUBLIC WAREHOUSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PUBLIC WAREHOUSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BULK STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BULK STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BULK STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PALLETIZED STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PALLETIZED STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PALLETIZED STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY RACK STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY RACK STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY RACK STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNERSHIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LONG TERM LEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LONG TERM LEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LONG TERM LEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SHORT TERM LEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SHORT TERM LEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SHORT TERM LEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DIRECT OWNED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DIRECT OWNED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DIRECT OWNED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY JOINT VENTURE OWNED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY JOINT VENTURE OWNED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY JOINT VENTURE OWNED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ANIMAL PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ANIMAL PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ANIMAL PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OVER THE COUNTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OVER THE COUNTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRESCRIPTION DRUGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRESCRIPTION DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNERSHIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNERSHIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNERSHIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNERSHIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNERSHIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNERSHIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNERSHIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNERSHIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNERSHIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 195. GCC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. GCC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
  • TABLE 197. GCC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, 2018-2032 (USD MILLION)
  • TABLE 198. GCC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. GCC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, 2018-2032 (USD MILLION)
  • TABLE 200. GCC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 201. GCC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. GCC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNERSHIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. GCC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 204. GCC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 205. GCC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 206. GCC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNERSHIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNERSHIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 231. G7 WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. G7 WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
  • TABLE 233. G7 WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, 2018-2032 (USD MILLION)
  • TABLE 234. G7 WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. G7 WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, 2018-2032 (USD MILLION)
  • TABLE 236. G7 WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 237. G7 WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. G7 WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNERSHIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. G7 WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 240. G7 WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 241. G7 WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 242. G7 WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 243. NATO WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. NATO WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
  • TABLE 245. NATO WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, 2018-2032 (USD MILLION)
  • TABLE 246. NATO WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. NATO WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, 2018-2032 (USD MILLION)
  • TABLE 248. NATO WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 249. NATO WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. NATO WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNERSHIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. NATO WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 252. NATO WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 253. NATO WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 254. NATO WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 255. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNERSHIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 269. CHINA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA WAREHOUSING IN PHARMACEUTICAL LOGIST